| References |
1.
Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin.
M.Manning et al., Int. J. Pept. Protein Res., 32, 455 (1988)
2.
Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
A.Asakawa et al., Gut, 52, 947 (2003)
3.
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
P.J.Woll and E.Rozengurt, Proc. Natl. Acad. Sci. USA, 85, 1859 (1988)
4.
Block of the hyoscine-resistant opiate withdrawal contracture of ileum by a new substance P antagonist [D-Arg1,D-Phe5,D- Trp7,9,Leu 11]substance P.
K.Tsou et al., Eur. J. Pharmacol., 110, 155 (1985)
5.
[D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.
J.G.Reeve and N.M.Bleehen, Biochem. Biophys. Res. Commun., 199, 1313 (1994)
6.
Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.
D.A.Jones et al., Peptides, 16, 777 (1995)
7.
Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro.
P.Heinz-Erian et al., Gastroenterology, 90, 1455 (1986)
8.
High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.
H.Houben and C.Denef, Peptides, 14, 109 (1993) |